Leptin revisited: its mechanism of action and potential for treating diabetes

Roberto Coppari,Christian Bjørbæk
DOI: https://doi.org/10.1038/nrd3757
IF: 112.288
2012-08-31
Nature Reviews Drug Discovery
Abstract:Key PointsLeptin is a hormone that is produced by adipose tissue and regulates appetite, body weight, neuroendocrine functions and glycaemia.In this Review, we first discuss data from leptin-based clinical trials. The results from these trials indicate that leptin therapy fails to improve metabolic defects in people who have elevated levels of circulating leptin and hence are leptin-resistant. Conversely, regardless of the disease context, leptin therapy is very effective in improving metabolic imbalances in individuals who have severe hypoleptinaemia.The defects underlying leptin resistance could include impaired transport of leptin across the blood–brain barrier, impaired neuronal leptin signalling in target neurons and altered signalling in downstream targets. Evidence suggests that activation of inflammatory pathways and endoplasmic reticulum stress contribute to the development of leptin resistance.In the presence of insulin, the glucose-lowering effects of leptin are probably mediated by leptin receptor (LEPR)-expressing neurons within the arcuate nucleus of the hypothalamus: specifically, by pro-opiomelanocortin (POMC)-expressing neurons. The neurocircuitry controlled by POMC-expressing neurons could be exploited to lower glycaemia in patients with type 2 diabetes.In the absence of insulin, the glucose-lowering effects of leptin are probably also mediated by LEPR-expressing neurons within the brain, but the biochemical identity of these neurons is still unknown. Once identified, this brain-controlled pathway could be exploited to improve hyperglycaemia in patients with type 1 diabetes.A better understanding of the leptin–CNS (central nervous system)–glycaemia pathway is clearly needed, as this may provide opportunities for the identification of new drug targets and therapeutics that can circumvent the obstacle of leptin resistance and ultimately help to improve the quality and length of life of the millions of people suffering from obesity and/or diabetes.
pharmacology & pharmacy,biotechnology & applied microbiology
What problem does this paper attempt to address?